Genetically Engineered Humanized Mouse Models: A Critical Tool for Studying Immunotherapy Drugs

July 13, 2023

Genetically Engineered Humanized Mouse Models: A Critical Tool for Studying Immunotherapy Drugs

Immunotherapy and cell therapy have revolutionized the field of cancer treatment by harnessing the power of the immune system to fight cancer cells. However, the development of effective immunotherapy drugs such as immune checkpoint inhibitors requires extensive preclinical testing to ensure safety and efficacy. Breakthroughs in the field are faced with several challenges including the generation of appropriate humanized mouse models for preclinical evaluation. Among others, genetically-engineered mouse models have emerged as valuable tools for improving cancer treatment outcomes.

History of CAR T-cells and Their Continued Use in Hematological Malignancies to Advance Next-Generation Therapies

CAR T-cell therapy originated in the late 1980s, first-generation constructs lacked adequate co-stimulatory signaling, causing poor CAR T-cell ...

Read more +

Cancer Support: Contract Research Organizations, More Than a Vendor, a Partner In Drug Development.

Developing cancer therapies is an incredibly complex, costly, and highly regulated journey. To navigate this challenging terrain, pharmaceutical and ...

Read more +

Advancing Bone and Sarcoma Cancer Research Through Robust In Vivo Models

Bone cancers and soft tissue sarcomas represent a diverse group of rare malignancies arising from mesenchymal tissues including bone, muscle, fat, ...

Read more +

Get Started

Contact Us Today!

If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.